[关于贝希特综合征的更新]
Ina Kötter1,2, Nikolas Ruffer3, Martin Krusche3
1III. Medizin, Sektion für Rheumatologie und Entzündliche Systemerkrankungen, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland. i.koetter@uke.de.
Zeitschrift fur Rheumatologie
|October 1, 2024
概括
贝切特综合征 (BS) 现在被归类为MHC-I病变,弥合自身炎症和自身免疫性疾病. 最近的进展包括对这种复杂的血管炎的精细诊断标准和新的治疗目标.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 遗传学 是一个遗传学.
背景情况:
- 贝切特综合征 (BS) 是一种复杂的血管炎,其特点是多器官参与.
- 了解它的病理生理学已经进化,将其定位在自身炎症和自身免疫性疾病之间.
研究的目的:
- 概述过去两年在贝希特综合征研究和临床实践中的最新创新.
- 突出了解病理生理学,诊断和治疗方面的进展.
主要方法:
- 在PubMed中使用关键字"Behçet"进行了文献搜索,从2022年到2024年.
- 文章的选择是基于与贝希特综合征最近的创新相关性.
主要成果:
- 贝赫特综合征现在被归类为MHC-I-病变,强调了HLA类I抗原在其发病过程中的作用.
- 确立了诊断标准 (ICBD 2014),但在低患病率地区的挑战表明可能需要进行调整.
- 疾病集群在地理位置和年龄上有所不同;大腿静脉的超声波和特定的口腔口腔特征有助于诊断.
- 皮肤病测试的敏感性可以通过肺炎球菌抗原来提高.
结论:
- BS的发病包括与HLA类I抗原的强烈关联,将其置于MHC-I-病变.
- 正在出现精细的诊断方法和对疾病表型的理解.
- 较新的生物药物和JAK抑制剂在治疗不耐药的贝赫特综合征方面表现有前途,预计将更新EULAR建议.
相关概念视频
Chronic Bowel Disorders: Introduction
403
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
403
Inflammatory Bowel Disease II: Crohn's Disease
194
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
194
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
146
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
146
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
Endocarditis II: Clinical features and Diagnostic Tests
2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2


